Published in Pain on August 25, 2010
A comprehensive review of rapid-onset opioids for breakthrough pain. CNS Drugs (2012) 0.93
Considerations in selecting rapid-onset opioids for the management of breakthrough pain. J Pain Res (2013) 0.92
Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip. Drug Dev Ind Pharm (2012) 0.91
Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain. Support Care Cancer (2011) 0.90
Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy. Adv Ther (2014) 0.80
Management of predictable pain using fentanyl pectin nasal spray in patients undergoing radiotherapy. J Pain Res (2013) 0.78
Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial. J Pain Symptom Manage (2016) 0.76
Single-dose fentanyl sublingual spray for breakthrough cancer pain. Clin Pharmacol (2013) 0.75
Fentanyl for breakthrough cancer pain--what's new? Pain (2010) 0.75
Fentanyl Pectin Nasal Spray reduces breakthrough cancer pain intensity compared with placebo in people taking at least 60 mg daily oral morphine or equivalent. Evid Based Nurs (2011) 0.75
Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain. J Pain Res (2016) 0.75
Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment. PLoS One (2017) 0.75
[Rapid release fentanyl administration forms. Comments of the Working Group on Tumor Pain of the German Pain Society]. Schmerz (2013) 0.75
Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician (2007) 3.05
Randomized open-label phase II study of decitabine in patients with low- or intermediate-risk myelodysplastic syndromes. J Clin Oncol (2013) 2.42
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin Cancer Res (2008) 1.63
The role of opioids in cancer pain management. Pain Pract (2005) 1.42
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance. Pain Physician (2012) 1.42
A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clin J Pain (2006) 1.38
Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med (2013) 1.36
NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw (2009) 1.35
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment. Pain Physician (2012) 1.24
Interventional techniques in the management of chronic spinal pain: evidence-based practice guidelines. Pain Physician (2005) 1.24
Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage (2007) 1.24
A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician (2012) 1.24
Practice guidelines for the prevention, detection, and management of respiratory depression associated with neuraxial opioid administration. Anesthesiology (2009) 1.18
Quantitative sensory findings in patients with bortezomib-induced pain. J Pain (2006) 1.16
Prevalence and characteristics of breakthrough pain in opioid-treated patients with chronic noncancer pain. J Pain (2006) 1.16
A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. J Thorac Oncol (2010) 1.16
Ordered silicon vacancies in the framework structure of the zeolite catalyst SSZ-74. Nat Mater (2008) 1.11
Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician (2003) 1.10
Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J Neurosurg Spine (2012) 1.09
An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Pract (2002) 1.04
Current challenges in cancer pain management: does the WHO ladder approach still have relevance? Expert Rev Anticancer Ther (2007) 1.03
Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain. Pain Physician (2011) 1.02
Hydrocodone use and sensorineural hearing loss. Pain Physician (2007) 0.99
Intrathecal ziconotide for neuropathic pain: a review. Pain Pract (2009) 0.95
23. Pain in patients with cancer. Pain Pract (2011) 0.94
Percutaneous vertebroplasty and kyphoplasty performed at a cancer center: refuting proposed contraindications. J Neurosurg Spine (2005) 0.94
Urine drug testing: current recommendations and best practices. Pain Physician (2012) 0.93
Fentanyl pectin nasal spray in breakthrough cancer pain. J Support Oncol (2010) 0.93
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myeloma. Clin Pharmacokinet (2009) 0.92
Long-term tolerability, efficacy and acceptability of fentanyl pectin nasal spray for breakthrough cancer pain. Support Care Cancer (2011) 0.90
Comorbid illness affects hospital costs related to hip arthroplasty: quantification of health status and implications for fair reimbursement and surgeon comparisons. J Arthroplasty (2004) 0.89
Partial Pyridoxine Responsiveness in PNPO Deficiency. JIMD Rep (2012) 0.89
Clinical implications of chemotherapy-induced diarrhea in patients with cancer. J Support Oncol (2005) 0.88
Spinal cord stimulation relieves chemotherapy-induced pain: a clinical case report. J Pain Symptom Manage (2004) 0.88
Pacemaker complication during magnetic resonance imaging. J Am Coll Cardiol (2005) 0.87
Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology (2015) 0.86
Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty. J Pain (2012) 0.85
Premature adjacent vertebral fracture after vertebroplasty: a biomechanical study. Neurosurgery (2011) 0.84
The role of chemical neurolysis in cancer pain. Curr Pain Headache Rep (2010) 0.83
All-human microphysical model of metastasis therapy. Stem Cell Res Ther (2013) 0.83
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trial. Cancer Immunol Immunother (2013) 0.82
Opioid abuse in cancer pain: report of two cases and presentation of an algorithm of multidisciplinary care. Pain Physician (2011) 0.81
Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module. J Neurosurg Spine (2010) 0.81
Throwing patterns used by collegiate baseball players in actual games. Res Q Exerc Sport (2002) 0.81
Re: video-assisted thoracoscopic sympathectomy-splanchnicectomy. J Pain Symptom Manage (2002) 0.80
Treatment of chemotherapy-induced anemia in breast cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40,000 U weekly. Clin Breast Cancer (2005) 0.79
Percutaneous vertebroplasty of a myelomatous compression fracture in the presence of previous posterior instrumentation. Report of two cases. J Neurosurg Spine (2006) 0.78
EMM-23: a stable high-silica multidimensional zeolite with extra-large trilobe-shaped channels. J Am Chem Soc (2014) 0.78
Structure-directing roles and interactions of fluoride and organocations with siliceous zeolite frameworks. J Am Chem Soc (2011) 0.78
Vertebroplasty in the management of painful bony metastases. Curr Pain Headache Rep (2009) 0.78
Percutaneous vertebroplasty in vertebra plana secondary to metastasis. J Spinal Disord Tech (2004) 0.78
Introducing interventional pain services in a large african teaching hospital: challenges and opportunities. Pain Pract (2013) 0.77
The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage (2003) 0.77
Treatment of refractory ischemic pain from chemotherapy-induced Raynaud's syndrome with spinal cord stimulation. Pain Pract (2007) 0.76
Breakthrough pain in opioid-treated patients with neuropathic pain. J Opioid Manag (2007) 0.76
Preliminary evaluation of an educational model for promoting positive team attitudes and functioning among pain medicine fellows. Pain Med (2010) 0.76
Palliative care and pain medicine come together to optimally treat cancer pain: what we can learn from the British Pain Society. Pain Med (2010) 0.75
Commissural myelotomy in the treatment of intractable visceral pain: technique and outcomes. Stereotact Funct Neurosurg (2010) 0.75
Spirituality and chronic illness. JAMA (2002) 0.75
Letter to the editor: pharmacokinetics of non-intravenous formulations of fentanyl. Clin Pharmacokinet (2013) 0.75
Management of cancer pain. JAMA (2004) 0.75
Dorsal root ganglion stimulation yielded higher treatment success rate for CRPS and causalgia at 3 and 12 months: randomized comparative trial. Pain (2016) 0.75
Two-tuohy needle and catheter technique for fluoroscopically guided percutaneous drainage of spinal epidural abscess: a case report. Pain Med (2009) 0.75
Treatment of contact dermatitis associated with spinal cord stimulator pulse generator--technical note. Neuromodulation (2012) 0.75
Update on adjuvant medications for chronic nonmalignant pain. Pain Pract (2003) 0.75
A study of piperidinium structure-directing agents in the synthesis of silica molecular sieves under fluoride-based conditions. J Am Chem Soc (2007) 0.75
Diquaternary ammonium compounds in zeolite synthesis: cyclic and polycyclic N-heterocycles connected by methylene chains. J Am Chem Soc (2009) 0.75
An analysis of the variability of breakthrough pain intensity in patients with cancer. J Community Support Oncol (2014) 0.75
The story of the Texas Pain Society: formation and function of a regional pain society. Pain Pract (2011) 0.75